MWAM
NVO

Manhattan West Asset Management’s Novo Nordisk NVO Stock Holding History

Manhattan West Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Buy
42,665
+10,854
+34% +$514K 0.31% 67
2025
Q4 		$1.62M Sell
31,811
-8,558
-21% -$438K 0.33% 66
2025
Q3 		$2.24M Buy
40,369
+11,278
+39% +$660K 0.47% 56
2025
Q2 		$2.01M Buy
+29,091
New +$1.98M 0.46% 57

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Manhattan West Asset Management's NVO Position: Q1 2026 in Review

Manhattan West Asset Management increased its Novo Nordisk (NVO) stake by 34% in Q1 2026, buying an estimated $514K and bringing the position to 42,665 shares worth $1.57M. The position accounts for 0.31% of the portfolio, ranked #67.

Manhattan West Asset Management first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.24M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Manhattan West Asset Management held 42,665 shares of Novo Nordisk worth $1.57M as of Q1 2026.
  • Manhattan West Asset Management bought 10,854 Novo Nordisk shares in Q1 2026, an estimated $514K.
  • Novo Nordisk made up 0.31% of Manhattan West Asset Management's portfolio in Q1 2026, its #67 holding.
  • Manhattan West Asset Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • Manhattan West Asset Management's Novo Nordisk position peaked at $2.24M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Manhattan West Asset Management's 13F filing for Q1 2026, filed 14 May 2026.